Savara faces an FDA setback for Molbreevi, its aPAP treatment. Learn how the company plans to recover and file a new BLA by ...

Replimune Group, Inc. faces FDA setbacks with RP1, raising financial risks and dilution concerns. Click here to find out why ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

The Baloch Liberation Army has claimed responsibility for a bomb blast in Quetta that killed Major Anwar Kakar, a senior ...

The Election Commission said on Tuesday that 26 lakh electors have shifted to different constituencies, while another seven lakh have enrolled at two places.

Security forces killed four BLA terrorists in an intelligence-based operation in Kalat, Balochistan, according to ISPR. The hideout was destroyed and a large cache of weapons recovered. The operation ...

These updates support Ocugen in its efforts to pursue its goal of 3 biologics license applications (BLA) in the next 3 years.

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Replimune Group, Inc. ("Replimune or the "Company") (NASDAQ: REPL).

Amid the dusty plateaus and strategic choke points of Balochistan, a covert conflict is rapidly intensifying — one that ...

Vusolimogene oderparepvec is a genetically modified herpes simplex type 1 virus designed to directly destroy tumors and generate an anti-tumor immune response.

The Baloch Army (BLA) has claimed responsibility for an attack on a bus carrying Pakistan Army personnel in the Quetta and ...